ALDH1A1 and neoplasm: Among ALDH1A1 selective inhibitors, a potent theophylline-based molecule, called NCT-501, has demonstrated in vitro efficacy on chemotherapy-resistant ovarian and HNSCC cell lines and reduction of tumor growth in vivo (93).